The aim of this study is to describe the survival and relapses of patients with diagnosis of acute lymphoblastic leukemia at two tertiary level hospitals in the metropolitan area of the valley of Mexico
Retrospective, observational study in patients with diagnosis of acute lymphoblastic leukemia, according to the criteria of the World Health Organization, from July, 2016, to October, 2020. The patients were cared for in the hematology department of the Hospital General de Mexico and in the hematology department of the Hospital Regional de Alta Especialidad Ixtapaluca. Relapse was considered in those cases with more than 5% of blasts in bone marrow and as relapse to the central nervous system with the presence of blasts in cerebrospinal fluid.
Study Type
OBSERVATIONAL
Enrollment
56
Hospital Regional de Alta Especialidad de Ixtapaluca
Ixtapaluca, State of Mexico, Mexico
Hospital General de México "Dr. Eduardo Liceaga"
Mexico City, Mexico
Overall survival
Time frame: 4-years
Progression free survival
Time frame: 4-years
Number of relapses
Cases with more than 5 percent of blasts in bone marrow and as relapse to the central nervous system with the presence of blasts in cerebrospinal fluid
Time frame: 4-years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.